NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Ethos Research Report

Summary We reiterate our BUY recommendation on Ethos, driven by the company's 'ahead-of-the-curve' investments in people, luxury real estate, and a strengthened balance sheet of Rs8 billion in cash.

Growth Prospects Ethos expects minimal disruption from the ongoing war in the Middle East, with robust growth trends and no major supply chain disruption. The company also benefits from tangible tailwinds in terms of gradual elimination of customs duty, lower discounting, and ramp-up of recent luxury locations. 100 boutiques are expected to be opened over the next 3-4 years, with 75-80% of the targeted expansion driven by non-metro stores.

Product Performance Favre Leuba has seen a better-than-expected launch, with approximately 6,000 pieces sold in the first year at an average selling price of Rs350,000. The lifestyle segment is also seeing strong initial traction for Rimowa and Messika.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

Valuations Ethos's valuations at 40x/30x FY27E/FY28E EPS are attractive, given strong ~30% earnings CAGR over FY26-28E. We reiterate our BUY recommendation with a target price of Rs3,200 (30x Dec-27E EBITDA).

Investor Takeaway

Investors should consider buying Ethos due to its 10x scale-up opportunity over the next decade.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.